'Incredibly upsetting': breast cancer patients dealing with shortage of common drug treatment

12 November 2019 - When Tricia Smith tried to fill her prescription for tamoxifen two weeks ago, she was shocked ...

Read more →

Women living with metastatic breast cancer in British Columbia now have public access to Kisqali

23 October 2019 - Novartis Pharmaceuticals Canada is pleased to announce that British Columbia will now reimburse Kisqali (ribociclib) for eligible ...

Read more →

Novartis completes certification of initial sites in Quebec for first approved Canadian CAR-T therapy, Kymriah (tisagenlecleucel)

9 October 2019 - Quebec government to reimburse Kymriah therapy for certain patients with life-threatening cancers who are in critical ...

Read more →

Health‐related quality of life in oncology drug reimbursement submissions in Canada: a review of submissions to the pan‐Canadian Oncology Drug Review

23 September 2019 - In Canada, CADTH evaluates and makes recommendations for the reimbursement of cancer drugs. One component of ...

Read more →

Addition of Kisqali to drug plan in Quebec expands access to treatment for metastatic breast cancer

19 September 2019 - Provincial reimbursement provides public access to treatment that may delay the progression of advanced breast cancer. ...

Read more →

Medexus reports Health Quality Ontario recommends Gliolan for public reimbursement

12 September 2019 - Medexus Pharmaceuticals today announced that Health Quality Ontario, under the guidance of the Ontario Health Technology ...

Read more →

Quebec becomes first province to list Lonsurf (trifluridine/tipiracil) for public reimbursement for adult patients with metastatic colorectal cancer

19 August 2019 - Cancer treatment taken orally shown to extend overall survival in patients whose disease has progressed following treatment ...

Read more →

Costing methods applied to cancer

8 August 2019 - Health care is vital in improving quality and length of life.  ...

Read more →

Cancer doctors are calling for a permanent fix to drug shortages in Canada

5 August 2019 - Three chemotherapy cancer drugs face national shortages, putting pressure on health care providers. ...

Read more →

New drug helps extend survival rate of men with advanced prostate cancer: B.C. Cancer Agency study

10 June 2019 - At two years, advanced prostate cancer patients taking the trial drug, in addition to their standard treatment, ...

Read more →

New genetic therapies in cancer treatment could impact benefits plans

12 April 2019 - In September 2018, Health Canada approved, for the first time, the use of a chimeric antigen ...

Read more →

A patient’s journey with melanoma and drug coverage concerns

22 March 2019 - Living her best life with her husband Jeremy, Karen Formosa was looking forward to retiring within ...

Read more →

Will price be a barrier to new cancer immunotherapy?

19 January 2019 - Advisory group CADTH recommends no funding for new CAR-T therapy until drug company lowers cost. ...

Read more →

Gene therapy drug Kymriah should be publicly covered if manufacturer drops price, report recommends

16 January 2019 - A groundbreaking gene therapy for cancer could cost the Canadian health care system more than $400 ...

Read more →

2019 oncology drugs in pipeline — survey

14 December 2018 - pCODR is again undertaking its periodic survey to facilitate consistent and systematic data collection from participating ...

Read more →